SIKHONATHI MANTSHANTSHA, Former Deputy Editor: Financial Mail

Loading player...
Day one of former Public Investment Corporation (PIC) chief executive Dan Matjila’s testimony at the commission of inquiry got off to an uneventful start on Monday, with the former head focusing mainly on the role he played in turning the PIC into South Africa’s biggest asset manager.

Matjila had been at the PIC for 15 years after being seconded to the institution as a risk manager by then CEO Brian Molefe in 2003. He became chief investment officer in 2005, and CEO in 2014.

He took the commission through the state asset manager’s corporatisation, and how he was instrumental in turning the institution from managing just over R300 billion when he arrived to having over R2 trillion in assets under management at the time of his departure in 2018.

Late submissions

However, Matjila’s much-anticipated testimony was cut short because he had only provided the commission with his final 227-page statement on Friday afternoon. On Monday, the commission said it was yet to receive his complete bundle of annexures, after Matjila’s counsel faced difficulties obtaining the relevant documents from the PIC.
9 Jul 2019 12PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min